BUSINESS
Alembic Pharmaceuticals gets USFDA’s final approval for Cyclophosphamide Capsules
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cyclophosphamide Capsules, 25 mg and 50…